By more than a 3-to-2 margin, school district electors passed a $53 million referendum to reduce the number of elementary school buildings and construct a new elementary school at a central location ...
PulseSight plans to submit a phase I clinical trial authorization (CTA) by the end the year, to be closely followed by a phase II proof-of-concept to demonstrate the efficacy and the safety of its ...